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SUMMARY		Protein-coding	mutations	in	the	transcription	factor-encoding	gene	ARX	cause	various	forms	of	intellectual	disability	(ID)	and	epilepsy.	In	contrast,	variations	in	surrounding	non-coding	sequences	are	correlated	with	milder	forms	of	non-syndromic	ID	and	autism	and	had	suggested	the	importance	of	ARX	gene	regulation	in	the	aetiology	of	these	disorders.	We	compile	data	on	several	novel	and	some	already	identified	patients	with	or	without	ID	that	carry	duplications	of	ARX	genomic	region	and	consider	likely	genetic	mechanisms	underlying	the	neurodevelopmental	defects.	We	establish	the	long-range	regulatory	domain	of	ARX	and	identify	its	brain	region-specific	autoregulation.	We	conclude	that	neurodevelopmental	disturbances	in	the	patients	may	not	simply	arise	from	increased	dosage	due	to	ARX	duplication.	This	is	further	exemplified	by	a	small	duplication	involving	a	non-functional	ARX	copy,	but	with	duplicated	enhancers.	ARX	enhancers	are	located	within	a	504	kb	region	and	regulate	expression	specifically	in	the	forebrain	in	developing	and	adult	zebrafish.	Transgenic	enhancer-reporter	lines	were	used	as	in	vivo	tools	to	delineate	a	brain	region-specific	negative	and	positive	autoregulation	of	ARX.	We	find	autorepression	of	ARX	in	the	telencephalon	and	autoactivation	in	the	ventral	thalamus.	Fluorescently	labeled	brain	regions	in	the	transgenic	lines	facilitated	the	identification	of	neuronal	outgrowth	and	pathfinding	disturbances	in	the	ventral	thalamus	and	telencephalon	that	occur	when	arxa	dosage	is	diminished.	In	summary,	we	have	established	a	model	for	how	breakpoints	in	long-	range	gene	regulation	alter	the	expression	levels	of	a	target	gene	brain	region-specifically	and	how	this	can	cause	subtle	neuronal	phenotypes	relating	to	the	aetiology	of	associated	neuropsychiatric	disease.		 	
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INTRODUCTION	Approximately	5-10%	of	X-chromosome	Linked	Intellectual	Disability	(XLID)	cases	are	caused	by	mutations	in	ARX,	encoding	the	aristaless	related	homeobox	transcription	factor	(Bienvenu	et	al.	2002;	Partington	et	al.	2004).	Both	polyalanine	expansions	and	coding	sequence	mutations	of	ARX	lead	to	ID	accompanied	by	other	clinical	comorbidities	including	lissencephaly,	epilepsy	and	infantile	spasms,	and	hand	dystonia	with	varying	severity	(Stromme	et	al.	2002;	Bienvenu	et	al.	2002;	Gecz	et	al.	2006;	Kitamura	et	al.	2009).	Whereas	disruptions	in	ARX	coding	sequence	cause	developmental	defects,	polyalanine	expansions	have	been	associated	with	nonsyndromic	ID	as	well	as	epilepsy	(Price	et	al.	2009;	Shoubridge	et	al.	2010).	Mouse	models	of	Arx	deficiency	as	well	as	polyalanine	expansions	identified	Arx	as	an	important	regulator	of	telencephalic	development,	showing	that	defects	in	tangential	migration	and	differentiation	of	GABAergic	and	cholinergic	neurons	are	potentially	cardinal	developmental	defects	leading	to	ID	and	lissencephaly	(Kitamura	et	al.	2002;	Kitamura	et	al.	2009).	Recent	mutation	screening	in	families	with	ID	and/or	autism	identified	three	distinct	point	mutations	in	ultraconserved	non-coding	sequences	in	the	vicinity	of	ARX	that	were	correlated	to	autism	and	infantile	spasms	(Fullston	et	al.	2011).	While	the	pathogenicity	of	these	mutations	was	not	assessed,	their	predicted	cis-regulatory	function	suggested	functionality	in	these	patients.	The	transcriptional	cascade	modulating	Arx	is	connected	to	Dlx	transcription	factor	function	and	promotes	GABAergic	neuron	development	in	the	telencephalon	and	other	parts	of	the	forebrain	(Colasante	et	al.	2008).	It	regulates	diverse	aspects	of	neurogenesis	such	as	neuronal	stem	cell	proliferation,	migration	and	differentiation	(Colombo	et	al.	2004;	Friocourt	et	al.	2006;	Colombo	et	al.	2007;	Friocourt	et	al.	2008).	Consequently,	its	target	genes	function	in	neuronal	differentiation	and	axonal	guidance,	but	also	in	synaptic	activity	(Seufert	et	al.	2005;	Fulp	et	al.	2008).	Many	of	these	are	correlated	with	schizophrenia,	intellectual	disability,	autism(s)	and	depressive	disorders,	stressing	the	importance	of	Arx-regulated	signaling	pathways	for	development	and	functioning	of	the	forebrain	(Quillé	et	al.	2011).	
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Arx	functions	in	multiple	organs	during	vertebrate	development	(Miura	et	al.	1997;	Biressi	et	al.	2008;	Collombat	et	al.	2009;	Djiotsa	et	al.	2012).	Usually,	genes	with	pleiotropic	functions	have	multiple	enhancers	that	orchestrate	their	regulation	in	time	and	space	(Komisarczuk	et	al.	2009).	Such	regulatory	domains	can	be	very	large	and	can	encompass	several	genes	of	which	one	is	the	target	gene	of	the	enhancers	as	this	was	revealed	by	testing	of	human	and	zebrafish	non-coding	sequences	in	transgenic	zebrafish	(Navratilova	et	al.	2009;Fredman	et	al.	2009;	Navratilova	et	al.	2010).	Defined	as	genomic	regulatory	block	(GRB),	this	contains	the	target	gene,	unrelated	non-target	genes	and/or	a	gene	desert	harboring	multiple	regulatory	sequences	(Kikuta	et	al.	2007a;	Kikuta	et	al.	2007b;	Becker	and	Lenhard	2007).	A	breakage	within	this	region	would	disturb	the	regulation	of	the	target	gene	and	consequently	a	GRB	is	evolutionary	conserved	in	all	vertebrate	genomes.	About	300	of	such	large	regulatory	domains	have	been	discovered,	with	the	Arx	gene	locus	being	one	of	these	(Engstrom	et	al.	2008).	A	41	kb	tandem	duplication	of	ARX	and	surrounding	sequences	was	discovered	in	a	patient	with	moderate	non-syndromic	XLID	(Whibley	et	al.	2010).	The	upstream	breakpoint	in	this	patient	is	within	the	5’untranslated	UTR	of	ARX,	leaving	the	duplicated	copy	without	promoter.	In	consequence,	the	only	genetic	abnormality	in	this	patient	is	a	duplication	of	enhancers	acting	on	ARX.	A	similar	ARX	duplication	with	a	breakpoint	within	or	near	the	5’UTR	of	ARX	has	recently	been	described	in	an	affected	boy	and	his	normal	grandfather	(Popovici	et	al.,	2014).	We	identified	four	more	ID	patients	with	duplications	including	ARX	and	describe	six	cases	that	are	available	in	DECIPHER	database.	The	duplicated	genomic	regions	vary	in	sizes	and	often	include	or	break	further	genes.	In	order	to	shed	light	on	the	disturbed	genetic	mechanisms	in	these	patients,	we	have	analyzed	the	regulation	of	ARX	in	zebrafish.	Zebrafish	and	mammalian	forebrains	have	many	regional	anatomical	homologies.	These	were	established	by	expression	pattern	similarities	of	evolutionary	conserved	genes,	which	function	in	the	production	of	molecularly	defined	neural	phenotypes	both	during	development	and	adulthood	(Osório	et	al.	2010;	Mueller	et	al.	2011;	Mueller	2012).	For	instance	regions	such	as	the	
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subpallium,	the	preoptic	region,	prethalamus	and	hypothalamus	are	defined	by	the	activity	of	genes	important	for	the	production	of	GABAergic	neurons	(Mueller	and	Wullimann	2002;	Filippi	et	al.	2014).	Using	zebrafish	transgenesis	we	established	the	long-range	regulatory	domain	of	ARX	and	identified	enhancers	to	characterize	their	brain	region	specific	activity.	Three	of	the	enhancers	mediate	autoregulatory	mechanisms	that	are	likely	critical	to	maintain	proper	expression	levels	of	the	gene	in	specific	regions	of	the	developing	forebrain.	The	transgenic	GFP	lines	served	as	in	vivo-markers	to	establish	loss	of	function	phenotypes	within	the	labeled	regions	of	Arx	activity.	Remarkably,	inhibition	of	arxa	function	in	embryos	of	these	lines	has	revealed	that	arxa/ARX	disturbances	have	very	subtle	effects	on	neuronal	outgrowth	and	guidance	that	likely	affect	the	formation	of	neuronal	circuits.	Without	suitable	markers	and	tools	such	delicate	defects	are	usually	overlooked	and	will	remain	mostly	undiscovered	in	patients.	Our	nomenclature	for	human,	zebrafish	and	pan-vertebrate	orthologs	is	ARX,	arxa	and	Arx,	respectively.	With	this	study	we	exemplify	how	genomic	rearrangements	and	duplications	can	cause	brain	region-	specific	expression	level	changes	that	result	in	relatively	subtle	neurological	disturbances	finding	their	appearance	in	a	neuropsychiatric	phenotype.		
MATERIAL	AND	METHODS	
Patients	The	screening	protocols	were	approved	by	the	appropriate	institution	review	boards	and	informed	consent	was	obtained	from	the	parents	of	patients.	Genomic	DNA	from	patients	and	healthy	controls	was	isolated	from	peripheral	blood	according	to	standard	procedures	and	stored	at	4oC.	
Array	cGH	Genomic	DNA	from	patient	and	control	samples	was	extracted	from	blood	collected	using	EDTA	as	the	anticoagulant.	High-resolution	chromosomal	
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microarray	and	analysis	was	conducted	by	contributing	cytogenetic	diagnostic	laboratories.	UCSC	Genome	Browser	(GRCh37/	hg19	build)	Human	Genome	coordinates	were	used	for	the	annotation	of	the	copy	number	variants	identified.	
Zebrafish	maintenance	and	staging	Zebrafish	were	maintained	at	14	hours	light/10	hours	dark	cycle	at	28.7°C.	Embryos	and	larvae	were	staged	according	to	established	zebrafish	protocols	(Kimmel	et	al.	1995).	Zebrafish	maintenance	and	experiments	had	been	in	accordance	with	terms	and	conditions	of	the	University	of	Sydney	Animal	Ethics	Committee.	
Computational	analyses		The	regulatory	domain	of	ARX	was	defined	by	analyzing	conserved	gene	order	in	vertebrate	genomes.	Synorth	genome	browser	(Dong	et	al.	2009)	was	used	to	establish	an	overview,	while	the	actual	size	and	coordinates	of	the	human	synteny	block	was	established	by	a	method	where	smoothened	HCNE	densities	were	used	to	estimate	the	edges	followed	by	visual	inspection	on	Ancora	browser	(Engstrom	et	al.	2008).	Conserved	non-	coding	sequences	were	extracted	using	the	following	thresholds:	human-mouse	>96%	over	50	bp,	human-	mouse	>90%	over	50	bp	and	human-frog	>70%	over	50	bp.	In	addition	we	determined	the	most	conserved	sequences	in	the	ARX	locus	by	utilizing	blastn	search	with	human	(GRCh37)	and	mouse	(mm9,	chrX:89473103-91500000)	genome	sequences	(Berman	et	al.	2000).	We	also	compared	to	ENCODE	data,	as	DNAse	hypersensitive	sites	(DHS)	and	ChIP	sequencing	signals	predict	enhancers.	However,	almost	all	available	datasets	had	been	generated	in	non-neural	cell	lines,	and	most	elements	did	not	reveal	specificities	in	public	datasets	other	than	DHS.	Some	were	identified	as	enhancers	through	p300	ChIP	sequencing	and	subsequent	validation	in	the	mouse	(Vista	Enhancer	Browser;	enhancer.lbl.gov/).	The	coordinates	and	length	of	all	tested	elements	as	well	as	reference	data	are	listed	in	Supplement	Table	1.	The	JASPAR	CORE	database	(http://jaspar.cgb.ki.se/)	(Sandelin	et	al.,	2004a)	and	ConSite	(http://consite.genereg.net/cgi-bin/consite)	(Sandelin	et	al.,	2004b)	were	used	to	identify	the	putative	transcription	factor	binding	sites	(TFBSs).	The	
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TFBSs	were	selected	using	Human	and	mouse	matrices	with	thresholds	above	95%.	
Zebrafish	reporter	gene	transgenesis	and	constructs	Sequences	chosen	for	testing	were	PCR	amplified	from	human	genomic	DNA.	The	fragments	were	cloned	upstream	of	a	gata2	promoter	into	a	Tol2	-	GFP	reporter	gene	vector	and	purified	construct	DNA	was	injected	into	fertilized	zebrafish	eggs.	Cloning	procedure,	microinjection,	raising	and	screening	of	fish	as	well	as	imaging	have	been	described	in	detail	(Ishibashi	et	al.	2013).	For	each	construct	at	least	four	positive	founders	were	isolated	to	give	rise	to	independent	transgenic	lines	and	F1	embryos	were	used	for	GFP	expression	pattern	analyses.	For	the	expression	of	Gal4,	the	GFP	was	exchanged	with	a	‘Kal4’	(Distel	et	al.	2009)	in	the	Tol2	reporter	gene	construct.	For	overexpression	of	arxa,	a	Tol2	reporter	gene	construct	was	modified	in	two	steps	to	co-express	the	cDNA	and	a	red	fluorescent	mCherry	as	a	marker.	First,	a	bidirectional	5	x	UAS	–	E1b	promoter	sequence	was	inserted	in	between	mCherry	and	a	Gateway®	recombination	cassette,	second,	a	SV40	sequence	was	inserted	upstream	of	the	GW	cassette.	Zebrafish	arxa	cDNA	was	amplified	from	a	cDNA	clone	(IMAGE:9038800,	gene	bank	ID:	BC163872)	with	following	primer	sequences:	forward	CGAGCACGACTGAGGACGAT,	reverse	GGATCAGCACACTTCTTTCCCT	and	then	subcloned	into	pCR8	plasmid	to	create	an	entry	vector.	A	clone	containing	arxa	cDNA	in	reverse	orientation	was	used	for	Gateway	recombination	into	the	Tol2	destination	vector.	The	construct	was	injected	into	wild	type	TAB	fish	and	fish	grown	to	adulthood	were	crossed	with	ARX_enhancer:Kal4	fish	to	be	screened	for	red	expression	and	to	establish	a	F1	generation.	F2	embryos	resulting	from	incrossed	F1	fish	were	used	for	analysis.	
Whole	mount	Anti-GFP	staining	Antibody	stainings	were	carried	out	according	to	a	protocol	described	previously	(Punnamoottil	et	al.	2008;	Turner	et	al.	2014).	Primary	antibodies:	rabbit	polyclonal	anti	GFP	antibody	(AMS	Biotechnology	cat	#	TP401)	at	1:1000;	mouse	monoclonal	anti	acetylated	tubulin	(Sigma	cat	#	T7451)	1:400.	Secondary	antibodies	were	used	from	Life	Technologies:	Alexa	Fluor®	488	goat	anti-rabbit	
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(A-11034)	and	Alexa	Fluor®	594	Chicken	Anti-Mouse	(A-21201).	Cell	nuclei	were	visualised	using	DAPI	(10	ug/ml	in	PBT	at	room	temperature	for	one	hour).	
Whole	mount	in	situ	hybridization	Embryos	were	fixed	in	4%	Paraformaldehyde	overnight	at	4oC,	then	subsequently	dehydrated	in	a	series	of	Methanol/PBT	(0.1%	Tween-20)	and	then	stored	at	-20°C.	The	hybridization	followed	a	standard	zebrafish	protocol	to	be	stained	by	an	alkaline	phosphatase	mediated	NBT/BCIP	staining	reaction	(Oxtoby	and	Jowett	1993).	Sectioning	was	described	in	(Punnamoottil	et	al.	2008).	The	DNA	template	for	arxa	probe	synthesis	was	kindly	provided	by	the	Kitamura	laboratory	and	linearized	with	SacI	to	be	transcribed	with	T3	polymerase	(Miura	et	al.	1997).	DIG-labeled	RNA	probe	was	used	at	a	concentration	of	1	ng/μl	hybridization	buffer.	Fluorescent	in	situ	protocol	was	modified	from	(Machluf	and	Levkowitz	2011).	Hybridization	solution	contained	2%	Dextran	Sulphate	and	probe	was	used	at	2-4	ng/ml.	Probe	was	detected	using	DIG	POD	antibody	(Roche	11207733910)	and	colour	was	developed	using	Tyramide	Signal	Amplification	(TSA)	kit#25	(Molecular	Probes	by	Life	Technologies	#	T-20935).	For	co-labelling	with	GFP	antibody	the	embryos	were	washed	5	times	for	15	minutes	with	PBT	(0.15%	Triton-X)	and	processed	according	to	standard	immunostaining	protocol	as	described	above.	Anatomical	nomenclature	followed	the	‘Atlas	of	early	zebrafish	brain	development’	by	Mueller	and	Wullimann,	2005).	
Morpholino	injections	arxa	translation	was	inhibited	using	two	morpholinos	(MOs)	that	had	been	described	in	our	previous	study	(Djiotsa	et	al.	2012).	The	first	targets	the	intron	2	-	exon	2	splice	junction	(5'	GCGTCATATTTACCTGGTGAACACA)	and	the	second	targets	the	ATG	(5'TCGTCGTCGTACTGACTGCTCATGA).	The	MOs	were	diluted	with	0.05%	Phenol	Red	and	2	ng	of	the	splice-MO	compared	to	3	ng	of	the	ATG-	MO	were	injected	into	the	yolk	at	the	1	cell	stage.	
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Morpholino	information	for	dlx2	genes	is	available	through	zfin.org	(MO1-dlx2a,	MO1-dlx2b;	Jackman	and	Stock,	2006)	and	target	the	5UTR/ATG.	dlx2a:	5	-	TGAGGCTGTCAAAAACTCCAGTCAT	–	3;	dlx2b:	5	–	GCTGTACTTCCTAACAGTTAATAGT	–	3.	The	Morpholinos	had	been	prepared	as	250	μM	solution	and	were	co-injected	in	the	amount	of	7.6	ng	(3.8	ng	each).	For	injection	zebrafish	eggs	were	collected	from	a	transgenic	parent	outcrossed	against	wild	type	fish.	100	fertilized	eggs	were	injected	with	the	antisense-morpholino	and	another	100	with	a	standard-control-Morpholino,	further	100	were	kept	non-	injected.	Embryos	were	analyzed	at	2	and	3	dpf	by	fluorescent	microscopy	using	an	inverted	microscope	(Leica	DMIL	LED).	15-20	embryos	each	batch	were	embedded	into	2%	methylcellulose	in	water	and	imaged.	Ten	of	these	were	selected	randomly	for	fluorescent	intensity	measurements	by	confocal	microscopy	on	day	three.	
Confocal	imaging	and	quantification	Imaging	was	performed	with	a	Zeiss	LSM	710	confocal	microscope	using	Zen	software.	Embryos	were	mounted	in	1-1.5%	low	melting	point	agarose	(Sigma	A9414)	in	a	glass-bottom	petri	dish.	For	fluorescent	intensity	measurements	each	embryo	was	quickly	scanned	to	define	the	appropriate	parameters,	which	allowed	signal	acquisition	for	all	samples	without	pixel	saturation.	All	embryos	(arxa	inhibited	and	controls)	were	then	scanned	using	the	same	parameters	including	laser	intensity,	pinhole,	detector	gain,	scan	speed,	temperature	and	objective.	An	average	of	90	slices	per	embryos	were	generated.	Integrated	fluorescent	density	minus	background	was	then	evaluated	for	each	projection	using	image	J	and	analysed	using	Microsoft	Excel.	Data	obtained	were	compared	using	a	t-test.	
Adult	brain	analyses	
A.	In	situ-hybridization:	3	to	9	month	old	wild-type	fish	(AB	strain)	were	culled	in	ice-water,	decapitated	and	the	dissected	brains	were	fixed	in	4%	formaldehyde	(wt/vol)	overnight	at	4°C.	Brains	were	dehydrated	in	ascending	MeOH	series	(25-100%,	5	min	each)	and	kept	at	-20°C	until	use.	The	brains	were	rehydrated	in	descending	MeOH	series	and	were	permeabilized	by	a	30	min	treatment	with	
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proteinase	K	(10	μg/ml;	P6556,	Sigma)	and	prehybridized	for	3	hours	at	65°C.	Hybridization	was	performed	at	65	°C	for	18	hours	in	hybridization	buffer	containing	DIG	labeled	arxa	probe	(Miura	et	al.	1997)	at	a	concentration	of	2ng/μl.	After	hybridization,	the	brains	were	embedded	in	3%	agarose	and	80	μm	thick	cross	sections	were	cut	using	a	vibratome.	The	sections	were	blocked	in	blocking	buffer	(2%	normal	goat	serum,	2mg/ml	bovine	serum	albumin),	incubated	with	anti-DIG	AP	Fab	fragments	(sheep,	Roche,	1:5000)	and	the	signal	was	developed	with	NBT/BCIP.	For	double	in	situ	hybridization	/	immunohistochemistry	staining	on	transgenic	brains,	in	situ	hybridization	was	performed	first	and	developed	with	SIGMAFAST	Fast	red/TR	Naphthol	(Sigma),	and	then	the	sections	were	rinsed	in	PBT	and	directly	processed	for	immunohistochemistry.	
B.	Immunohistochemistry	on	free-floating	sections:	50	μm	thick	vibratome	sections	were	blocked	in	blocking	buffer	(10%	goat	serum,	0.5%	triton	X-100	in	phosphate-buffered	saline)	for	1	hour	at	RT.	The	following	primary	antibodies	were	used:	GFP	(chicken,	1:500,	Aves	Laboratories),	HuC/D	(mouse,	1:600,	Invitrogen),	S100ß	(rabbit,	1:2000,	Dako)	and	TH	(mouse,	1:500,	Chemicon	MAB318,	recognizes	TH1)	diluted	in	blocking	buffer.	Secondary	antibodies	raised	in	goat	coupled	to	AlexaFluor	dyes	(Invitrogen)	were	used	in	1:1000	dilutions	for	2	hours	at	RT.	At	least	two	brains	were	analyzed	for	each	transgenic	line.	
C.	Image	acquisition:	Pictures	of	the	ISH	on	sections	were	taken	on	a	Nikon	AZ100	microscope	equipped	with	a	Nikon	DS	Ri1	camera.	Fluorescent	images	were	taken	on	a	Zeiss	LSM700	confocal	microscope	using	20x	air,	40x	oil	or	63x	oil	immersion	objectives.	Images	were	processed	using	the	ZEN	software	(Zeiss).	Composite	images	were	automatically	stitched	upon	acquisition	using	‘Tilescan’	mode	on	the	Zeiss	ZEN	software.	Anatomical	nomenclature	followed	Wullimann/Rupp/Reichert	1996	(Neuroanatomy	of	the	Zebrafish	brain,	A	topological	atlas).		
RESULTS	
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Genomic	dosage	imbalances	in	patients	with	XLID	Patients	with	various	neurodevelopmental	problems,	intellectual	disability	and	autism	were	identified	to	have	duplications	encompassing	the	ARX	gene	locus.	Table	1	lists	the	patients	(P)	in	the	order	as	they	appear	in	Figure	1	and	provides	specificities.	P505	is	a	previously	reported	patient,	who	displays	moderate	non-	syndromic	intellectual	disability	and	has	a	41	kb	tandem	duplication	that	includes	ARX	and	part	of	POLA1	(Whibley	et	al.	2010).	P1	presents	with	speech	delay	mild	intellectual	disability	and	hypotonia,	but	has	a	400	kb	duplication	with	breakage	of	POLA1.	P2,	the	mother	of	P1	has	only	mild	learning	difficulties.	P3	and	his	sister	P4	have	poor	growth	and	delayed	speech.	Their	maternally	inherited	duplication	encompasses	all	of	POLA1	and	19	kb	sequence	upstream	of	ARX,	which	is	in	antisense	direction.	DECIPHER	has	recorded	six	further	male	patients	(DP1-5),	who	presented	with	phenotypes	including	intellectual	disability	with	speech	and/or	language	delay.	Other	comorbidities	include	autism,	ADHD	and	poor	growth.	All	duplications	encompass	ARX	and	have	breakpoints	in	POLA1,	except	DP1	and	DP2,	with	a	full	duplication	of	POLA1	and	disruption	of	PCYT1B.	One	more	case	was	mapped,	P5,	who	presented	with	autism	and	mild	developmental	delay.	The	0.549	Mb	duplication	is	approximately	100	kb	downstream	of	ARX	and	includes	PCYT1B,	PDK3,	while	POLA1	appears	disrupted.	In	contrast,	DECIPHER	patient	DP6,	who	inherited	from	a	normal	parent	a	9	kb	small	deletion	70	kb	upstream	of	ARX,	does	not	present	any	particular	phenotype.	Although	some	of	the	duplications	are	larger	and	include	duplications	of	POLA1	(P3,	P4,	DP1,	DP2)	as	well	as	breakage	of	POLA1	(P1/P2,	DP3,	DP4,	DP5)	and	PCYT1B	(DP1,	DP2),	these	genes	are	not	associated	with	central	nervous	system	disorders.	
The	long-range	regulatory	domain	of	ARX	and	search	for	enhancers	Conserved	synteny	of	human	ARX	and	surrounding	HCNEs	with	the	zebrafish	genome	was	used	as	criterion	to	identify	the	regulatory	domain	of	the	gene.	ARX	is	in	conserved	gene	order	with	PDK3-PCYT1B-POLA1	in	most	vertebrates.	In	
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zebrafish	the	synteny	block	is	split	into	pdk3a	-	pcyt1ba	and	pola1	–	arxa	(illustrated	in	Synorth	genome	browser	(Dong	et	al.	2009),	suggesting	that	the	majority	of	the	enhancers	regulating	ARX	are	within	the	POLA1-ARX	region.	This	locus	contains	88	sequences	with	more	than	96%	conservation	over	50	bp	between	human	and	mouse	(red	bars	in	Fig.	2a).	The	density	of	such	highly	conserved	non-coding	sequences	(HCNEs)	is	highest	around	ARX	and	extends	into	POLA1.	Fourteen	of	these	sequences	with	highest	conservation	score	in	blastn	searches	and	a	further	twelve	sequences	conserved	more	than	70%	over	50	bp	between	human	and	frog	genomes	(green	bars	in	Fig.	2a)	were	tested	for	enhancer	function	by	reporter	gene	transgenesis	in	zebrafish	(hs1	–	hs26,	coordinates	and	primers	listed	in	Suppl.	Table	1).	In	addition,	we	chose	two	sequences	that	were	identified	as	poised	enhancers	in	human	embryonic	stem	cells	with	the	prediction	that	these	would	be	active	in	differentiated	cells	and	tissues	(Rada-Iglesias	et	al.	2011).	hs8	was	separated	into	hs8a	and	hs8b.	Mouse	orthologous	sequences	of	hs2,	hs3,	hs8a	and	hs8b	were	found	to	bind	enhancer-associated	protein	p300	in	the	developing	forebrain	(Visel	et	al.	2009).	In	our	assay	nineteen	sequences	drove	GFP	expression	in	defined	tissues	in	at	least	two	out	of	four	independent	transgenic	zebrafish	lines	(Fig.	2b/c,	Suppl.	Table	1).	As	defined	by	the	major	arxa	expression	domains	in	zebrafish	(telencephalon,	diencephalon	and	floor	plate)	we	further	established	if	these	regulate	ARX	specifically	(Fig.	2c).	Sequences	hs2,	hs8a,	hs8b,	hs9	and	hs13	had	specific	activity	and	were	identified	as	enhancers	of	ARX	(Fig.	2d/e).	The	other	sequences	may	influence	ARX	gene	regulation,	but	were	not	conclusive.	
Brain	region	specific	enhancer	activity	of	ARX	We	found	that	zebrafish	arxa	is	strongly	expressed	in	GABAergic	forebrain	regions,	i.e.,	the	subpallium,	the	preoptic	region,	the	ventral	thalamus,	the	(caudal)	hypothalamus	and	the	ventral	posterior	tubercular	region	(Fig.	2e,	Suppl.	Fig.	1).	Weak	expression	was	also	detected	in	the	developing	dorsal	telencephalon	(pallium)	and	the	thalamic	eminence,	both	of	which	at	this	stage	are	thought	to	consist	of	primarily	glutamatergic	neurons.	These	expression	domains	are	highly	consistent	with	findings	in	mice	(Colombo	et	al.	2004),	suggesting	that	arxa	and	Arx	have	a	conserved	role	in	GABAergic	neuron	
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specification	and	migration	from	fish	to	mammals.	In	addition	arxa	and	Arx	may	function	in	the	development	of	glutamatergic	territories	such	as	the	thalamic	eminence	and	pallium.	Figure	2f	illustrates	the	gross	similarities	between	the	zebrafish	and	the	mammalian	telencephalon	(modified	from	(Folgueira	et	al.	2012).	The	specific	regulatory	activities	of	the	brain	enhancers	were	analyzed	in	more	detail	by	confocal	imaging	of	transgenic	embryos	(Fig.	3a-e)	and	colocalization	of	the	GFP	with	arxa	mRNA	transcripts	was	confirmed	(Suppl.	Fig.	2).	hs2	regulates	a	broad	pattern	within	the	arxa	expression	domain	covering	clusters	of	neurons	in	the	dorsomedial	and	ventral	telencephalon,	the	dorsolateral	ventral	thalamus,	the	preoptic	region,	the	caudal	hypothalamus,	the	midbrain	basal	plate	and	hindbrain	floorplate	(Fig.	3a).	In	contrast	to	hs2,	hs8b	regulates	expression	in	the	whole	ventral	thalamus	and	the	GFP	distributes	in	projections	leading	into	the	habenular	commissure	(Fig.	3b)	(Wilson	et	al.	1990;	Barresi	et	al.	2005).	hs8a	has	regulatory	functions	in	the	dorsomedial	telencephalon,	the	anterodorsal	ventral	thalamus,	the	ventral	posterior	tuberculum	and	the	caudal	hypothalamus	(Fig.	3c).	The	strong	activity	of	hs8a	in	the	dorsal	telencephalon	(i.	e.	pallium)	was	found	in	contrast	to	arxa	expression,	which	is	normally	only	weak	in	this	region	(compare	to	Fig.	2f,	Suppl.	Fig.	1).	Despite	the	small	overlap	in	the	anterodorsal	ventral	thalamus,	hs8a	and	hs8b	fragments	have	almost	mutually	exclusive	regulatory	activity	(see	double	labeling	image	in	Fig.	3d),	which	is	combined	when	both	sequences	are	tested	together	in	one	construct	(Fig.	3e).	Neuronal	projections	in	hs8a	and	hs8b:GFP	transgenic	larvae	were	strongly	labeled	and	were	analyzed	in	detail	(Suppl.	Fig.	3).	hs13	drove	GFP	in	a	very	similar	pattern	to	hs8a	in	the	dorsal	telencephalon,	posterior	tuberculum	and	caudal	hypothalamus	at	3	dpf	(Fig.	3c),	however	at	1	dpf	and	at	later	stages	the	activity	of	the	enhancers	differed	(Suppl.	Fig.	4).	In	summary,	all	enhancers	have	distinct,	but	also	overlapping	functions	in	regulating	ARX	expression	in	the	developing	forebrain.	
ARX	enhancer	activity	in	the	adult	brain	arxa	expression	pattern	was	established	in	the	adult	zebrafish	brain	and	the	activity	of	the	identified	enhancers	was	compared.	Only	hs2	was	found	to	act	
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specifically	in	adults.	arxa	transcripts	were	detected	in	the	dorsal	nucleus	of	the	ventral	telencephalon	(Fig.	4a,	Vd),	which	corresponds	to	the	dorsal	subpallium	and	is	equivalent	to	the	striatum	in	mammals	(Rink	and	Wullimann	2004).	hs2	was	found	to	be	active	in	this	region,	but	the	expression	was	mosaic	(Fig.	4a).	Posterior	of	the	Vd,	arxa	transcripts	were	detected	in	the	supracommissural	nucleus	of	the	ventral	telencephalic	area	and	in	the	ventromedial	thalamic	nucleus	(data	not	shown).	arxa	mRNA	was	further	identified	in	the	caudo-ventral	diencephalon,	including	in	the	periventricular	nucleus	of	the	posterior	tuberculum	(TPp),	where	a	small	subpopulation	of	neurons	was	positive	for	tyrosine	hydroxylase	1	(TH)	(Fig.	4b).	The	posterior	tuberculum	contains	dopaminergic	neurons	and	its	axonal	projections	into	the	dorsal	subpallium	had	identified	both	structures	as	the	equivalent	of	the	nigro-striatal	system	in	mammals	(Rink	and	Wullimann	2001;	Wullimann	and	Mueller	2004;	Forlano	and	Bass	2011).	hs2-	driven	GFP	overlapped	arxa	mRNA	in	the	TPp,	but	again	was	mosaic	(Fig.	4b).	GFP	was	also	seen	in	areas	where	arxa	transcripts	were	either	below	detection	levels	or	absent:	in	the	ventral	nucleus	of	the	ventral	telencephalon	(Vv),	dorsally	to	neurons	of	the	medial	zone	of	dorsal	telencephalon	(Dm)	and	in	the	posterior	zone	of	the	dorsal	telencephalon	(Dp)	(Fig.	4a).	Since	hs2	extends	its	regulatory	function	into	adult	stages	it	might	be	possible	that	this	enhancer	may	control	expression	of	ARX	in	processes	relating	to	neuronal	function	or	maintenance.	
Negative	autoregulation	of	ARX	in	the	developing	brain	Arx	gene	regulation	is	known	to	respond	to	Dlx2	(Colasante	et	al.	2008)	and	we	wondered	if	ARX-transgenic	lines	would	function	as	sensors	to	establish	which	of	the	enhancers	would	respond	to	dlx2.	Morpholino	antisense	oligonucleotides	(MO)	were	used	to	inhibit	dlx2a	and	dlx2b	translation	and	it	was	subsequently	established	whether	the	enhancers	had	altered	activity	as	evaluated	by	increased	or	decreased	GFP	expression.	No	significant	changes	in	GFP	expression	and	on	arxa	transcript	level	could	be	detected.	We	next	asked	if	identified	ARX	enhancers	would	mediate	autoregulatory	functions	in	the	brain	(Fig.	5a).	The	knockdown	of	arxa	in	hs9:GFP	and	hs13:GFP	embryos	had	no	significant	effect	
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on	enhancer	activity	(Suppl.	Fig.	5a),	while	the	GFP	in	hs2	and	hs8a	transgenic	embryos	was	significantly	upregulated	and	indicated	that	Arxa	normally	has	a	suppressive	effect	on	these	enhancers	(Suppl.	Fig.	5b,	5c).	Knockdown	of	arxa	in	line	hs8b:GFP	altered	the	GFP	expression	domain.	The	GFP	disappeared	from	the	medial	ventral	thalamus,	while	expression	in	the	lateral	ventral	thalamus	became	stronger	(red	asterisks	in	Fig.	5a	and	d).		We	next	asked	if	a	negative	autoregulation	was	reflected	at	the	arxa	transcript	level.	In	situ	hybridization	analysis	of	arxa	morphants	compared	to	controls	revealed	an	accumulation	of	arxa	transcripts	in	the	developing	brain	(Fig.	5b).	This	identified	domains	of	low-level	transcription	in	wildtype	embryos	(Fig.	5b).	One	example	is	the	normally	very	weak	expression	of	arxa	in	the	pallium	of	wildtype	embryos	(compare	section	1	in	Fig.	5c	to	section	1	in	Suppl.	Fig.	1).	Another	example	is	the	telencephalic	migrated	area	that	normally	had	only	very	faint	staining	(compare	section	2	in	Fig.	5c	to	sections	2	and	3	in	Suppl.	Fig.	1).	In	summary,	we	have	discovered	a	negative	autoregulatory	feedback	mechanism	of	ARX	that	is	mediated	through	hs2,	hs8a	and	hs8b	enhancers.	In	addition,	hs8b	may	require	activation	through	ARX	in	the	medial	ventral	thalamus.	
Brain	region-specific	positive	autoregulation	of	ARX	In	order	to	test	a	putative	positive	feedback	mechanism	in	ARX	regulation,	we	overexpressed	zebrafish	arxa	cDNA	using	hs8a,	hs8b	and	hs13	enhancers.	In	this	experimental	design	increased	fluorescent	expression	should	be	seen	when	Arxa	transcription	factor	would	signal	back	to	the	enhancer	(either	directly	or	indirectly).	Transgenic	lines	in	which	hs8a,	hs8b	and	hs13	drive	a	Gal4	were	crossed	into	transgenic	lines	carrying	a	bidirectional	UAS:arxa/:mCherry	cassette.	F2	larvae	expressed	mCherry	and	arxa	cDNA	in	enhancer-specific	brain	regions	and	were	compared	to	specimen	not	overexpressing	arxa	(Fig.	6).	A	definitive	effect	of	Arxa	on	hs13	could	not	be	established	(data	not	shown).	hs8a-driven	overexpression	of	arxa	increased	activation	of	the	enhancer	in	the	medial	ventral	thalamus	(Fig.	6a),	which	is	a	strong	regulatory	domain	only	at	1	dpf	(Suppl.	Fig.	4).	This	was	in	contrast	to	hs8a	activity	in	the	telencephalon,	which	appeared	unaltered	or	perhaps	weaker.	hs8b	responded	to	increased	Arxa	
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with	enhanced	activity	in	the	medial	part	of	the	ventral	thalamus	where	neurons	projecting	laterally	were	strongly	labeled	(Fig.	6b).	The	complex	positive	and	negative	autoregulation	through	hs8a	and	hs8b	is	illustrated	in	Fig.	6c.	Of	note,	hs8a-driven	overexpression	of	arxa	in	the	telencephalon	caused	variable	malformations	becoming	obvious	by	displacement	of	the	eyes	towards	the	midline	(Suppl.	Fig.	6).	We	concluded	from	our	experiments	that	ARX	is	positively	autoregulated	in	the	ventral	thalamus,	which	occurs	at	sequences	that	are	within	hs8a	and	hs8b	enhancers.	
Knockdown	of	arxa	disturbs	ventral	thalamic	and	telencephalic	
development	Abrogated	arxa	function	led	to	disturbances	in	ventral	forebrain	development	as	visualized	by	hs8a	and	hs8b-	driven	GFP.	GFP	served	as	marker	for	neurons	with	arxa	identity	and	since	this	distributes	uniformly	in	the	cell,	neuronal	projections	are	also	visible	as	described	in	Suppl.	Fig.	3a-d.	Arxa	antisense	morpholinos	were	injected	into	fertilized	eggs	of	hs8a	and	hs8b	transgenic	lines	and	GFP	labeled	neuronal	projections	were	analyzed	at	3	and	6	dpf	and	compared	to	those	of	control	embryos	(Fig.	7a,b).	Prominently	and	as	described	above	(Fig.	4),	hs8b	driven	GFP	was	missing	from	the	medial	domain	of	the	ventral	thalamus	(marked	by	the	red	asterisk	in	Fig.	7a).	In	contrast,	the	lateral	expression	domain	was	slightly	expanded,	which	resulted	in	a	more	prominent	fiber	bundle	originating	in	this	region	(orange	arrows	in	Fig.	7a).	Neuronal	projections	that	originate	in	the	medial	ventral	thalamus	and	that	project	into	the	tectum	(blue	arrows	in	Fig.	7a)	were	strongly	reduced	(blue	asterisks).	In	addition	to	the	phenotype	observed	in	the	ventral	thalamus	at	3	dpf,	we	detected	increased	fiber	outgrowth	towards	the	telencephalon	in	the	morphants	at	6	dpf	(pink	arrows	in	Fig.	7b)	and	caudally	directed	projections	(orange	arrows)	appeared	disorganized	at	that	stage.	hs8a:GFP	specimen	label	the	anterior	commissure,	which	connects	the	left	and	right	hemispheres	and	crosses	in	the	ventral	telencephalon	(Suppl.	Fig.	3).	This	appeared	diffuse	and	with	fewer	projections	in	arxa	knockdown	specimen	as	shown	in	representative	horizontal	optical	sections	in	Fig.	7c	(yellow	arrows).	
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Using	GFP-labeled	anterior	commissure	and	ventral	posterior	tuberculum	as	markers,	the	horizontal	views	also	illustrate	that	the	anterior-posterior	axis	of	the	ventral	telencephalon	and	diencephalon	was	shortened	(red	and	yellow	bars	in	Fig.	7c).	This	points	to	more	severe	disturbances	in	the	ventral	forebrain	after	knockdown	of	arxa.	The	specific	reporter	lines	facilitated	the	detection	of	morphological	and	neuronal	wiring	defects	in	the	ventral	forebrain	when	arxa	function	is	disturbed	and	will	provide	useful	in	vivo	tools	for	future	functional	studies	on	arxa.					
DISCUSSION	This	study	has	identified	several	novel	patients	and	collected	information	on	existing	patients	with	moderate	intellectual	disability	presenting	delay	of	speech	development	as	their	common	symptoms,	with	all	of	them	having	genomic	duplications	that	include	the	transcription	factor	gene	ARX.	The	duplications	vary	in	sizes	and	include	further	genes,	of	which	none	are	correlated	with	brain	diseases.	Having	mapped	the	regulatory	domain	of	ARX	the	duplicated	genomic	fragments,	breakpoints	and	cis-regulation	can	now	be	put	into	context	(for	overview	see	Fig.	1	and	Table	1	lists	duplicated	enhancers).	Five	ARX	brain	enhancers	are	located	within	504	kb	around	the	gene	and	reveal	that	this	genomic	region	is	highly	functional	and	interactive	and	that	duplications,	dependent	on	the	specific	breakpoints,	will	disturb	gene	regulatory	mechanisms	by	enhancer	displacement.	The	identified	enhancers	are	specifically	active	in	the	telencephalon,	ventral	thalamus,	preoptic	region,	posterior	tuberculum,	caudal	hypothalamus	and	floorplate	with	partially	overlapping	functions.	Overlapping	enhancer	functions	are	known	to	regulate	genes	with	complex	spatio-temporal	expression	patterns	and	it	is	thought	that	these	are	critical	to	fine	tune	transcript	dose	(Komisarczuk	et	al.	2009;	McBride	et	al.	2011).	The	function	of	redundant	enhancers	is	also	to	provide	robust	buffering	in	differing	environmental	conditions	(Hong	et	al.	2008;	Frankel	et	al.	2010;	Perry	et	al.	2010).	
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The	duplication	of	patient	505,	which	displays	a	non-syndromic	intellectual	disability,	exemplifies	critical	ARX	gene	regulatory	functions	(Fig.	8).	P505	has	a	relatively	small	tandem	duplication	including	ARX	and	downstream	enhancers	(except	hs2).	We	found	the	breakpoint	in	5’untranslated	UTR,	which	implicates	that	the	promoter	is	missing	from	the	duplicated	copy.	Consequently,	the	additional	coding	sequence	cannot	be	transcribed,	but	the	duplicated	enhancers,	in	proximity	to	the	original	promoter,	have	most	likely	additional	regulatory	influence	on	ARX.	In	contrast,	hs2,	normally	located	112	kb	downstream	of	ARX,	is	brought	further	away	and	its	regulatory	influence	is	likely	diminished.	The	gene	regulatory	deficits	in	this	patient	could	be	exacerbated	by	disturbed	autoregulatory	mechanisms	as	enhancers	hs2,	hs8a	and	hs8b	respond	differentially	to	decreased	and	increased	Arxa	levels	in	the	zebrafish	model	(Fig.	5	&	6,	Suppl.	Fig.	5).	Decipher	patient	1	(DP1),	presenting	with	severe	intellectual	disability,	could	be	exemplary	for	a	duplicated	ARX	copy	that	may	also	lack	the	promoter	(the	inner	breakpoint	of	the	14	kb	mapped	interval	is	in	exon	1	at	chrX:25,033,815),	but	since	the	breakpoint	downstream	of	ARX	is	far	beyond	hs2,	the	gene	regulatory	domain	of	the	original	gene	(as	defined	through	the	location	of	the	five	brain	enhancers)	appears	non-disturbed.	This	patient	was	described	in	Popovici	et	al.	2014	as	Patient	2,	whereas	his	grandfather	(Patient	3	-	duplication	of	unknown	inheritance	pattern)	from	whom	he	had	inherited	the	duplication	appeared	normal.	Another	patient	presented	in	this	study	(Patient	1)	with	a	de	novo	ARX	duplication	covering	a	region	32	kb	downstream	of	hs2	to	1.7	kb	downstream	of	hs13	(chrX:24,861,402-25,398,496)	also	presented	without	ID.	It	has	to	be	mentioned	that	the	two	patients	presenting	without	ID	were	not	tested	for	mosaicism	(Popovici	et	al.	2014).	Somatic	mosaicism	for	CNVs	has	been	underappreciated	(Campbell	et	al.	2015)	and	in	these	individuals	it	could	potentially	explain	why	they	are	not	affected.	The	absence	of	ARX	duplications	in	the	Database	of	Genomic	Variants	and	subcellular	mislocalisation	of	overexpressed	ARX	(Shoubridge	et	al.	2010)	as	well	as	the	effect	of	ARX	overexpression	on	its	known	targets,	LMO1	and	SHOX2	(Shoubridge	et	al.	2012),	suggest	that	high	ARX	protein	dosage	is	likely	detrimental	to	the	cell.	Alternatively,	the	non-ID	phenotypes	of	patients	with	ARX	duplications	may	
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point	to	a	variable	phenotype	penetrance,	which	may	also	be	reflected	in	variable	physical	abnormalities	that	often	accompany	the	ID	(‘syndromic	ID’).	In	this	study	we	focus	on	ID	to	relate	disturbances	in	a	gene	regulatory	domain	to	a	neuronal	phenotype,	but	it	has	to	be	kept	in	mind	that	ARX	is	also	active	outside	the	nervous	system.	Expression	studies	in	zebrafish	and	mouse	show	that	arxa/Arx	is	for	example	expressed	in	the	myotome,	notochord/backbone,	limbs	and	craniofacial	skeleton	(Miura	et	al.	1997;	Collombat	et	al.	2003;	Norton	et	al.	2005;	Eurexpress	Transcriptome	Atlas,	www.eurexpress.org).	Since	we	have	tested	many	more	elements	than	we	present	here	as	enhancers,	with	many	of	these	having	activity	for	example	in	the	fins	and	notochord,	we	included	the	screening	results	of	the	transgenic	zebrafish	lines	in	Suppl.	Table	1	(for	interpretation	of	screening	results	see	Ishibashi	et	al.	2013).	It	would	be	too	speculative	at	this	point	to	invoke	putatively	disturbed	cis-regulatory	mechanisms	in	different	‘syndromic’	patients.	Morpholino	antisense	oligonucleotide	mediated	inhibition	of	arxa	translation	served	to	identify	autoregulatory	mechnisms	of	the	gene	(Fig.	5).	While	morpholinos	partially	loose	their	activity	starting	at	3	dpf	and	sometimes	cause	unspecific	effects,	we	have	compared	arxa	morpholino	injected	specimen	to	specimens	injected	with	control	morpholinos	in	all	experiments.	Hs8a	and	hs8b	enhancers	act	negatively	autoregulatory	in	the	pallium	and	in	the	lateral	ventral	thalamus	(summarized	in	Fig.	6c).	While	hs8a	has	strong	GFP	regulatory	activity	in	the	pallium,	Arxa	suppresses	the	activity	of	this	enhancer,	which	could	be	a	mechanism	to	reduce	arxa	transcript	levels	in	this	brain	region	(compare	Fig.	5b,c	and	Suppl.	Fig.	1).	From	prevented	transcription	of	arxa	(Fig.	5c)	and	missing	activation	of	hs8b-regulated	GFP	in	the	medial	ventral	thalamus	of	arxa	morpholino	injected	specimen	(Fig.	5d)	we	concluded	that	autoactivation	of	hs8b	enhancer	might	be	essential	for	ARX	expression	in	the	medial	region	of	the	ventral	thalamus.	This	positive	autoregulatory	feedback	loop	was	confirmed	through	hs8b	enhancer_Gal4-UAS	mediated	overexpression	of	arxa	in	the	zebrafish	model	(Fig.	6a,	b).	To	identify	potential	upstream	factors	and	signaling	pathways	that	regulate	the	enhancers	we	have	used	transcription	factor	binding	site	(TFBS)	prediction	tools	
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ConSite	and	Jasper	(Sandelin	et	al.	2004	a,b;	see	method	section).	Selected	TFBSs	that	bind	transcription	factors	with	expression	domains	(Allen	Brain	Atlas,	www.brain-map.org)	overlapping	that	of	Arx	are	presented	in	Suppl.	Fig.	7.	For	example,	Sox5	and	Sox17	signaling	may	act	on	hs2,	hs9	and	hs13	enhancers.	While	Sox5	is	highly	expressed	in	the	developing	cortex	and	the	dorsomedial	diencephalon,	Sox17	is	not,	but	was	found	to	control	cell	cycle	exit	of	oligodendrocyte	progenitor	cells	in	the	ventricular	zone	in	the	ventral	telencephalon	(ganglionic	eminences;	Sohn	et	al.	2006).	The	autoregulatory	mechanisms	identified	in	this	study	suggest	that	an	overall	transcript	increase,	as	expected	in	patients	having	the	whole	ARX	regulatory	region	duplicated,	would	lead	to	brain	region-specific	imbalances	in	ARX	expression.	DECIPHER	patients	DP3	and	DP4	have	such	duplications,	while	duplicated	regions	in	the	other	patients	lack	hs13.	Our	experiments	in	the	zebrafish	model	suggest	that	this	would	result	in	enhanced	activation	of	ARX	in	the	ventral	thalamus,	while	expression	in	the	cortex	would	be	expected	to	decrease.	In	general,	dependent	on	the	distance	of	the	enhancers	to	the	breakpoints	and	the	orientation	of	the	duplicated	fragments	in	the	genome,	enhancers	could	act	on	both	gene	copies	thereby	‘over’-regulating	ARX	brain	region-specifically.	The	autoregulatory	mechanisms	explain	how	a	general	increase	of	ARX	transcripts	would	exacerbate	expression	level	imbalances	in	the	critical	brain	areas,	including	the	ventral	thalamus,	which	was	previously	not	associated	with	ID.	The	ventral	thalamus	functions	in	memory	processing	and	thus	may	have	a	role	in	speech	learning,	which	is	a	major	deficit	in	all	described	patients	(Table	1)	(Cholvin	et	al.	2013).	Using	the	transparency	of	the	zebrafish	model	and	in	vivo	labeling	of	arxa	neurons,	we	have	shown	that	diminished	arxa	function	results	in	disturbances	in	neuronal	projections	in	the	ventral	thalamus	and	in	the	ventral	telencephalon	(Fig.	7).	Since	most	of	the	ID	patients	exhibit	only	a	delay,	but	not	the	inability,	of	speech	learning,	underdeveloped	neuronal	circuits	may	provide	a	reasonable	explanation	for	the	rather	subtle	phenotype	in	patients	carrying	ARX	genomic	rearrangements.	
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So	far,	ARX	mutations	have	been	mostly	associated	with	a	reduced	number	of	GABAergic	and	cholinergic	neurons	in	the	cortex,	occurring	through	inhibited	proliferation	of	intermediate	progenitor	cells	and	disturbed	migration	of	GABAergic	neurons	in	the	ganglionic	eminences	(Colasante	et	al.	2009;	Kitamura	et	al.	2009;	Colasante	et	al.	2013).	This	ventral	telencephalic	expression	domain	is	controlled	by	hs2,	not	only	during	development	but	also	in	the	adult	brain,	where	ARX	may	modulate	neuronal	function	(Beguin	et	al.	2013).	An	orthologous	sequence	of	hs7,	which	had	only	inconclusive	activity	in	our	assay	(Fig.	2b/c,	Suppl.	Table	1),	was	previously	identified	to	have	enhancer	function	in	this	area	(Suppl.	Table	1;	(Colasante	et	al.	2008).	This	is	of	special	interest	since	a	hs7	core-conserved	sequence	has	a	single	base	pair	change	in	a	family	with	ID	and	had	been	correlated	to	infantile	spasm	(uc467,	(Fullston	et	al.	2011).	The	same	study	reported	another	conserved	sequence	(uc466)	with	single	nucleotide	exchanges	in	two	patients	with	autism,	which	is	included	in	hs4.	This	sequence	had	also	only	variable	activity	in	zebrafish	(Suppl.	Table	1)	and	a	similar	fragment	was	inconclusive	in	the	mouse	(Visel	et	al.	2009;	Visel	et	al.	2013).	The	observed	abnormalities	in	axon	outgrowth	and	pathfinding	in	specimen	with	diminished	Arxa	function	may	provide	an	explanation	for	the	spectrum	of	neuropsychiatric	phenotypes	observed	in	patients	with	copy	number	variations	and	ARX	gene	regulatory	abnormalities.		
CONCLUSIONS	We	have	shown	that	enhancers	of	ARX	are	located	far	upstream	and	downstream	of	the	gene,	in	a	504	Kb	regulatory	domain,	which	makes	the	regulation	of	the	gene	vulnerable	to	genomic	rearrangements.	A	complex	autoregulation	of	ARX	further	implies	that	increased	expression	levels	due	to	duplicated	coding	regions	will	feed	back	into	brain	region-specific	transcriptional	control	and	will	amplify	the	effects	of	genome	dosage.	Genomic	rearrangements	as	observed	in	patients	with	ID	would	therefore	alter	ARX	transcript	levels	brain	region-specifically.	In	addition	to	formerly	reported	disturbances	in	the	ventral	telencephalon,	this	would	also	affect	neurons	and	neuronal	circuits	of	the	ventral	thalamus.		
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FIGURE	LEGENDS	
Table	1.		CNVs	in	Xp22.11	in	ARX	long-range	regulatory	domain.	Patients	(P)	are	listed	in	the	order	as	they	appear	in	Fig.	1.	Clinical	description,	duplication	details	and	other	specificities	are	provided.		
Fig.	1.	Duplications	of	ARX	and	its	regulatory	domain	in	patients	with	ID.		UCSC	browser	(hg19)	window	with	view	on	ARX,	flanking	UCSC	genes	and	genomic	rearrangements	in	patients	(P)	505	and	1-5	and	six	additional	cases	identified	from	DECIPHER	(DP1-6).	The	blue	bars	indicate	the	extent	of	the	duplications	in	males,	and	teal	bar	in	a	female,	with	the	red	bar	indicating	a	deletion	in	a	male.	The	location	of	ARX	enhancers	as	identified	in	this	study	are	indicated	below.		
Fig.	2.	Mapping	of	ARX	cis-regulatory	activity	in	the	developing	zebrafish	brain.		a.	Custom-modified	UCSC	genome	browser	window	comprising	1.86	Mb	of	the	human	X-chromosome	(hg19).	The	ARX	transcription	factor	gene	is	located	downstream	of	POLA1	and	transcribed	in	antisense	direction.	The	colored	little	bars	represent	non-coding	sequences	conserved	in	the	genomes	of	mouse	(dark	and	bright	red),	opossum	(blue),	frog	(green),	and	zebrafish	(dark	blue).	The	red	hill	above	reflects	their	density.	Highly	conserved	non-coding	element	(HCNE)	density	is	highest	around	ARX	and	POLA1.	The	grey	bars	at	the	bottom	show	elements	that	we	tested	in	zebrafish.	b.	The	expanded	window	of	623	kb	shows	detailed	location	of	tested	sequences	(excluding	hs16,	which	lies	almost	300	kb	downstream	of	hs13)	that	were	taken	into	analysis.	Elements	were	categorized	according	to	their	regulatory	activity.	Red-colored	enhancers	acted	highly	consistent	in	isolation	from	the	genomic	locus,	whereas	green-colored	sequences	expressed	variable	activity.	c.	Percentage	of	recurrence	of	GFP	reporter	gene	expression	in	arx	transcript	positive	tissues	in	at	least	four	different	transgenic	zebrafish	lines	for	each	of	the	tested	sequence.	d.	Representative	images	of	transgenic	2.5	dpf	embryos	with	ARX	brain	enhancers	regulated	GFP.	Arrows	point	to	the	expression	domains	in	a	color	code	that	corresponds	to	the	anatomical	descriptions	in	‘E’.	e.	Simplified	zones	of	arx	expression	in	2-3	dpf	
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zebrafish	embryos	in	lateral	view.	f.	The	telencephalon	compared	between	zebrafish	and	mammals	in	illustrations	of	transverse	sections.	The	red	colored	lines	point	to	different	morphogenesis	(eversion	in	zebrafish	versus	evagination	in	mammals).	These	schematics	are	modified	after	(Folgueira	et	al.	2012).	
Fig.	3.	ARX-enhancer	regulated	reporter	expression	in	the	brain.		Confocal	microscopy	images	of	representative	ARX-enhancer	regulated	fluorescent	reporter	expression.	a-e.	Horizontal	sections	of	2	and	3	dpf	embryos	are	shown	if	not	labeled	otherwise.	a.	hs2:GFP	embryos	at	2	dpf	in	three	orientations.	The	horizontal	optical	section	is	comparable	to	the	horizontal	section	in	B	and	shows	that	hs2	regulated	GFP	is	only	in	the	dorsolateral	region	of	the	VT,	whereas	hs8b	labels	all	VT.	The	series	of	transverse	sections	leads	from	anterior	to	posterior	through	the	forebrain	and	provides	a	frontal	view.	b.	hs8b	regulated	GFP	in	the	ventral	thalamus	(VT)	at	2	dpf.	White	arrows	point	to	the	habenular	commissure,	the	green	arrow	marks	fibers	that	project	ventrally.	c.	Enhancers	hs8a	and	hs13	drive	very	similar	expression	in	the	dorsal	telencephalon	at	3	dpf,	images	of	a	double	transgenic	embryo.	hs13	regulated	Gal4-UAS:Kaede	shown	as	3D	image	with	90°	rotation	below,	visualizes	projections	between	the	telencephalon	and	the	ventral	diencephalon.	d.	Co-regulated	hs8a:mCherry	and	hs8b:GFP	at	3	dpf	shows	almost	complementary	activity.	Orange	arrows	point	to	neuronal	projections	originating	dorsolateral	and	projecting	posterior,	and	grey	arrows	mark	fibers	originating	medial	and	projecting	dorsolateral.	e.	Combined	activity	of	hs8a	and	hs8b	in	element	hs8.	Transverse	optical	sections	through	the	forebrain	are	at	two	levels	with	the	upper	image	being	further	dorsal.	Abbreviations:	(AC)	anterior	commissure,	(F)	floor	plate,	(H)	hypothalamus,	(Hc)	caudate	hypothalamus,	(Hi)	intermediate	hypothalamus,	(OT)	optic	tectum,	(P)	pallium,	(Po)	preoptic	region,	(S)	subpallium,	(Tel)	telencephalon	(dorsal),	(VT)	ventral	thalamus.		
Fig.	4.	Adult	brain	analysis.	a./b.	Expression	of	arxa	as	revealed	by	chromogenic	in	situ-hybridization	and	expression	of	hs2-enhancer	regulated	GFP	in	the	adult	zebrafish	brain.	Representative	transverse	sections	document	arxa	mRNA	distribution	and	are	compared	to	confocal	optical	sections	of	immunostained	
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hs2:GFP	brains.	The	levels	of	sections	are	indicated	in	the	schematics.	a.	The	yellow	arrow	points	to	arxa	mRNA	transcripts	in	the	Vd.	A	corresponding	section	labels	GFP	(green)	with	a	DAPI	counterstain	in	hs2	transgenic	line	and	indicates	the	localization	of	four	nuclei	that	carry	abbreviations	(see	below).	The	rectangle	in	the	schematic	indicates	the	photographed	area	shown	in	the	magnified	images	below:	First	row:	An	overlap	of	fluorescent	arxa	hybridization	signal	and	hs2:GFP	in	Vd	is	marked	by	the	yellow	arrows;	Second	row:	Triple	immunostaining	for	GFP	(green),	HuC/D	(labeling	neurons,	magenta)	and	S100β	(labeling	radial	glial	cells,	blue)	shows	that	GFP	mostly	labels	neurons	(red	arrows)	and	occasional	radial	glial	cells	(blue	arrows).	b.	Focus	is	on	arxa	expression	domain	in	the	periventricular	posterior	tuberculum.	The	rectangle	indicates	the	region	that	is	magnified	in	the	images	below.	Images	of	a	single	confocal	optical	section	show	co-expression	of	hs2:GFP	and	arxa	mRNA	(marked	by	the	yellow	arrows).	A	small	subpopulation	of	arxa-positive	cells	also	expressed	TH1	(white	arrows).		Abbreviations:	(Dm)	medial	zone	of	the	dorsal	telencephalon,	(Dp)	posterior	zone	of	the	dorsal	telencephalon,	(PTv)	ventral	posterior	tuberculum,	(TPp)	periventricular	nucleus	of	the	posterior	tuberculum,	(Vd)	dorsal	nucleus	of	the	ventral	telencephalon,	(Vv)	ventral	nucleus	of	the	ventral	telencephalon.		
Fig.	5.	ARX	negative	autoregulation	in	the	forebrain.		arxa	function	was	inhibited	in	ARX_enhancer:GFP	lines	by	injection	of	antisense	morpholino	oligonucleotides	(MO).	GFP	intensity	was	used	as	a	measure	to	assess	the	activity	of	the	enhancers	(a).	a.	2	dpf	embryos	are	shown	in	different	orientations.	hs2	and	hs8a	regulated	GFP	was	significantly	enhanced	in	arxa-inhibited	embryos.	hs8b	regulated	domain	missed	GFP	in	the	medial	part	of	the	ventral	thalamus	(marked	by	a	red	asterisk).	Differences	in	hs9	and	hs13	regulated	GFP	expression	could	not	be	established.	See	also	Suppl.	Figures	5	and	6.	b.	arxa	in	situ	hybridisations	of	3	dpf	embryos.	The	regions	expressing	arxa	are	labeled	with	arrows	in	a	color-code	described	in	Fig.	1f	and	7c.	Fine	lines	carry	further	descriptions	that	use	nomenclature	established	in	the	‘Atlas	of	the	developing	zebrafish	brain’,	Mueller	and	Wullimann	(Elsevier).	arxa	MO	injected	and	control	embryos	(control	MO	
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and	non-injected,	NI)	had	same	staining	times,	but	the	morphants	developed	much	quicker	a	very	strong	signal	indicating	increased	arxa	transcript	levels.	A	wildtype	embryo	with	longer	staining	time	was	added	to	the	panel	for	proper	expression	pattern	comparison.	Black	arrows	point	to	the	medial	ventral	thalamus	(VT)	where	transcripts	were	missing	in	the	morphants.	c.	Two	transverse	sections	through	arxa	morphants	provide	further	details.	d.	The	area	in	the	medial	VT	that	missed	transcripts	(around	the	proliferative	zone	flanking	the	3rd	ventricle,	see	in	‘c’)	also	missed	hs8b	regulated	GFP	(horizontal	and	transverse	confocal	optical	sections).	Abbreviations:	(DT)	dorsal	thalamus,	(M4)	telencephalic	migrated	area,	(Sd)	dorsal	division	of	subpallium,	(Sv)	ventral	division	of	subpallium,	(TeO)	tectum	opticum.		
Fig.	6.	ARX	positive	autoregulation	in	the	ventral	thalamus.		Confocal	imaging	of	larvae	expressing	arxa	cDNA	and	co-regulated	mCherry.	Shown	are	representative	transverse	optical	sections	at	two	different	levels	from	dorsal	to	further	ventral.	Control	images	are	from	UAS:Kaede	expressing	larvae	and	carry	morphological	descriptions.	a.	hs8a	regulated	overexpression	of	arxa	in	the	dorsomedial	telencephalon	as	well	as	weakly	in	the	medial	region	of	the	ventral	thalamus	(VT).	The	weak	activity	of	hs8a	in	the	VT	triggered	a	positive	autoregulation	that	lead	to	activation	of	the	enhancer	as	indicated	by	strong	expression	of	the	mCherry	(marked	by	the	green	arrows).	b.	hs8b	activated	overexpression	of	arxa	in	the	ventral	thalamus.	Neuronal	projections	leading	dorsolateral	(grey	arrows)	appeared	increased.	The	expression	domain	appeared	widened	and	changed	the	triangle	into	a	square	shape.	This	is	due	to	increased	labeling	of	fibers	growing	from	medially	located	neurons	towards	lateral	in	the	ventral	half	of	the	expression	domain	(pointed	out	by	the	green	arrows).	c.	Summary	of	ARX	positive	and	negative	autoregulatory	mechanisms	through	hs8a	and	hs8b	enhancers	as	established	through	overexpression	of	arxa	and	arxa	morpholino	inhibition.	Basically,	ARX	enhancers	respond	brain	region-specific	to	arxa.		
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Fig.	7.	Morphological	changes	as	visualized	by	hs8b	and	hs8a	regulated	GFP.		a.	hs8b	regulated	GFP	labeled	VT.	Transverse	optical	sections	of	anti-GFP/anti	acetylated	tubulin	co-stained	embryos	provide	frontal	views	and	show	that	the	habenular	commissure	(white	arrows)	developed	normal.		Horizontal	z-stack	images	lead	through	the	dorsal	and	medial	VT	expression	domain	in	live	imaged	specimen.	Projections	from	VT	into	OT	(blue	arrows)	were	reduced	and	missing	(blue	asterisks).	GFP	appeared	enhanced	and	expanded	in	the	lateral	domain	with	originating	axonal	projections	leading	posteriorly	appearing	stronger	(orange	arrows).	Grey	asterisks	mark	the	area	where	VT	projections	towards	dorsolateral	were	strongly	reduced.	b.	Horizontal	z-stack	images	of	live	imaged	larvae	on	two	different	levels	of	the	VT	expression	domain.	Pink	arrows	point	to	fine	neuronal	projections	growing	towards	the	telencephalon	-	these	were	increased	as	well	as	disorganized	in	the	morphants,	while	neuronal	projections	projecting	dorsolateral	(blue	and	grey	arrows)	were	reduced.	Fiber	bundles	projecting	posteriorly	(orange	arrows)	had	stronger	label	in	the	morphants	and	appeared	misrouted.	c.	hs8a	regulated	GFP	labeled	the	telencephalon,	posterior	tuberculum	and	hypothalamus.	Representative	horizontal	optical	sections	of	6	dpf	larvae	show	that	the	anterior	commissure	appeared	diffuse	and	weakened	(marked	by	yellow	arrows).	Also	the	length	of	the	ventral	telencephalon	(red	bars)	and	the	distance	between	the	anterior	commissure	and	the	ventral	posterior	tuberculum	(yellow	bars)	appeared	reduced.		
Fig.	8.	Illustration	of	ARX	gene	regulatory	abnormalities	in	P505.	A	zoom	into	the	POLA-ARX	region	with	focus	on	the	41	kb	sequence	that	is	tandem	duplicated	in	P505,	modified	from	Fig.	1.	ARX	coding	sequence	is	in	reverse	orientation	mirroring	the	genomic	arrangement.	Tested	sequences	appear	in	red	(enhancers)	and	green	(inconclusive	cis-regulatory	activity).	hs7,	approximately	9	kb	distant	of	hs8a,	was	added	to	the	illustration	because	this	harbors	an	ultraconserved	sequence	carrying	a	mutation	in	a	patient	with	autism	and	was	identified	as	specific	enhancer	in	a	mouse	model	(Colasante	et	al.	2008;	Fullston	et	al.	2011).	Upstream	breakpoint	is	at	the	transcription	start	site	of	ARX	indicating	that	the	duplicated	copy	misses	a	functional	promoter.	Numbers	in	
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grey	give	the	distances	between	the	breakpoint	3’	of	the	gene	and	hs2,	hs7	respectively.	Abnormal	regulatory	influences	are	indicated	by	grey	arrows	with	numbers	in	red	giving	distances	between	enhancers	and	functional	ARX	promoter.	Autoregulatory	mechanisms	in	the	telencephalon	and	ventral	thalamus	are	not	emphasized	in	this	illustration.	In	essence,	with	the	duplicated	copy	being	non-functional,	hs2	enhancer	moved	further	away	from	the	gene	(170	kb	instead	of	112	kb)	subsequently	loosing	influence	on	ARX,	while	duplicated	enhancers	hs7	to	hs9	have	increased	regulatory	influence.	Since	DNA	folding	is	unknown	for	this	region,	the	model	remains	hypothetical.		
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Severe intellectual disability, microphthalmia, growth retardation, bisuspic aortic valve
No phenotype reported in Decipher 
Genes involved Duplicated enhancers Other chromosomal abnormalities / Comments References 
P505 Male Moderate non-syndromic intellectual disability Familial GAIN of 41 kb chrX:24992914 – 25033979 
Global Gender Clinical description Inheritance Gain Variant coordinates (hg19) and size 
ARX hs8a, hs8b, hs9 ARX copy non-functional Whibley et al 2010 
P1 Male Mild intellectual disability, speech delay and hypotonia Familial GAIN of 0.4 Mb chrX:24887676 - 25325777 ARX, POLA1 hs2, hs8a, hs8b, hs9 - This study 
P2 Female Learning difficulties Familial (Mother of P1) GAIN of 0.4 Mb chrX:24887676 - 25325777 ARX, POLA1 hs2, hs8a, hs8b, hs9 - This study 
P3 Male Developmental delay, growth retardation, delayed speech Familial GAIN of 0.377 Mb chrX: 24677441- 25054698 ARX, POLA1, hs2, hs8a, hs8b, hs9 
GAIN of Xp11.4 region spanning a min 0.071 Mb and max 0.161 Mb. Duplicates 
part of TSPAN7 gene, familial, unclear clinical significance. This study 
P4 Female Short stature and speech delay Familial (Sister of P3) Gain of 0.377 Mb chrX: 24677441- 25054698 ARX, POLA1, hs2, hs8a, hs8b, hs9 This study 
Decipher 253498 DP1 Male Familial Gain of 0.45 Mb chrX:24593306- 25033815 ARX, POLA1, PCYT1B hs2, hs8a, hs8b, hs9 ARX copy non-functional 
Popovici et al 2014 
(P2) 
Decipher P265145 
DP2 Male 
Autism, hyperactivity, delayed speech and language development, ADHD, other physical 
abnormalities unknown GAIN of 0.58 Mb 
chrX:24650157 - 
25230368 ARX, POLA1, PCYTB1 hs2, hs8a, hs8b, hs9 - 
Popovici et al 2014 
(P4) 
Decipher 266096 DP3 Male Generalized hypotonia, Microcephaly, other physical abnormalities unknown GAIN of 0.81 Mb chrX:24741372- 25554818 ARX, POLA1 
hs2, hs8a, hs8b, hs9, 
hs13 - 
Decipher P250183 
DP4 Male 
Delayed speech and language development, psychiatric abnormalities, Hyperactivity, 
Intellectual disability, Dysarthria De novo GAIN of 0.72 Mb 
chrX:24815107 - 
25542728 ARX, POLA1 
hs2, hs8a, hs8b, hs9, 
hs13 
GAIN of Xq25 of 0.41 Mb including STAG2 and XIAP – inherited from normal 
parent- unknown pathogenicity. 
Popovici et al 2014 
(P5) 
Decipher P277835 
DP5 Male Moderate intellectual disability Familial GAIN of 0.3 Mb 
chrX:24861601 - 
25163763 ARX, POLA1 hs2, hs8a, hs8b, hs9 - 
P5 Male Autism and mild developmental delay unknown GAIN of 0.549 Mb ChrX:24351258 - 24900393 
POLA1, PCYT1B, 
PDK3 
- - 
hs2 
GAIN of 3q11.1q11.2 of 0.929, incl. PROS1 and ARL13B. No clear clinical 
relevance for duplication of these genes. GAIN 4q35.2 of 0.597 Mb; GAIN 11.2q12 
of 0.439 Mb. No disease associated with gains. 
This study 
Decipher P267095 
DP6 Male No phenotype recorded in Decipher Familial LOSS of 0.09 Mb Xp21.3 - 
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Figure 8
HCNE ID Coordinate (hg19) Length (bp) Forward Primer Reverse Primer Vista Enhancer Browser Other References
Visel et al., 2013 (mouse) Expression Features Tested Sequences Expression Features
ARX_hs1 chrX:24,822,379-24,824,163 1785 AATGTTCATCAAGTGAGAGA CCACATAAATGTTCTAGAAG hs116 negative
ARX_hs2 chrX:24,894,335-24,896,084 1750 AGCAAGCATATGCATTTCAACAG TTTTGAGAATTGATTTTTCAGGTG hs118 midbrain
ARX_hs3 chrX:24,915,382-24,918,272 2891 GTGGACTTTGGGAGGAAAACAG ATTTGAGCAGAAAACAACTCCTG hs119 forebrain 
ARX_hs4 chrX:24,945,475-24,947,567 2093 AAAACGGTGGTATTAAAGCATT ATGTTACCAGTTTCTCCCTTGCT hs120 negative
   ARX_hs4S chrX:24,946,225-24,946,965 741 GCAAAATATGTCAGGAATCA CTACAATATGCATCATCATTA
   ARX_hs4L chrX:24,945,320-24,949,744 4425 GGACCTCATCAGAAATCTCA GCTGTGGAGATAGCTCAAGT
ARX_hs5 chrX:24,984,230-24,986,251 2022 AGTTTTCATTTGAAAAACTAGCA CTGCCACCATGGTACACTGA N.A. N.A.
ARX_hs6 chrX:24,998,179-25,000,979 2801 TTTCTCTGTTGTATGCATTAAT AATTTTAAAATATGGCTCACTC N.A. N.A.
Colasante et al., 2008 (mouse)
ARX_hs7 chrX:25,007,981-25,010,746 2766 GTTGAAGGTCAACATTTTGT AGGCAAAGACATTTTAACAT hs121 forebrain UAS3 (0.8kb; mm9 - ChrX:90,555,532–90,556,342)
   ARX_hs7S chrX:25,007,879-25,009,581 1703 GTGGGTGATGAACATGTTTTCTG AAAGCAATGTAAAGAATGCCACT
ARX_hs8 chrX:25,017,067-25,020,264 3198 TGGAGTTAATCTTGTGACTGTTGC ACTCCGTTCCCGGGTTTAGTA N.A. forebrain, eye, midbrain
UAS1- UAS2
(3.5kb; approximately 1.5kb downstream of Arx)
cx, eminentia thalami (et), vt, hy
   ARX_hs8a chrX:25,017,067-25,018,756 1690 TGGAGTTAATCTTGTGACTGTTGC TGTGATCTTACTAGAGTGACAAAAGG hs122 forebrain UAS2  (0.3kb; mm9 - ChrX: 90,548,333–90,548,660)
   ARX_hs8b chrX:25,018,992-25,020,264 1273 CTAAGATGCCCGCCCTGACTA ACTCCGTTCCCGGGTTTAGTA hs145 eye, forebrain, midbrain UAS1 ( 0.65kb; mm9 - ChrX: 90,546,954 –90,547,604)
ARX_hs9 chrX:25,026,079-25,028,244 2166 ACTGCATATCAGCTATTTTCA AAGTAGACCCAAGCACTCTCTCA N.A. N.A.
ARX_hs10 chrX:25,067,479-25,069,064 1586 TGAGCAGAGAGCAGCAGTTCAT TACTGAGACTGTTACATTTTC N.A. N.A.
ARX_hs11 chrX:25,037,049-25,038,881 1833 CTGGCTCCTCTAATCTTTGG AGAAAGCAGATGGTGGTGAT N.A. N.A.
ARX_hs12 chrX:25,212,479-25,213,879 1401 GCTAAGGTAGAGTAAGCAGT TGTAAAAGGTGAAGCAGTGT N.A. N.A.
ARX_hs13 chrX:25,400,224-25,402,334 2111 TGGAAACATTAAACAATTCAAGA CTTACCATTTGTGGACTTTGCTT hs123 forebrain
ARX_hs14 chrX:24,286,833-24,288,865 2033 CCAGAAAATGGAAGCAACAG AGGAATACTTCTTTCTGAGG N.A. N.A.
ARX_hs15 chrX:25,197,539-25,199,079 1541 AGGTTAGAATCAGTCAGGTA CAAAGTTTCATCTTTAGCCA N.A. N.A.
ARX_hs16 chrX:25,667,129-25,669,025 1897 ACATGCGTTCAACTGTTTTA TTATTTGCTGAGTTCATGAT N.A. N.A.
ARX_hs17 chrX:24,828,086-24,828,739 654 CATAACTGGTAACGTTTTTGTA AATTACAGGCTCCACAGACT N.A. N.A.
ARX_hs18 chrX:24,860,129-24,861,126 998 CTCTTACTTGAATGTGCTTG AAATGAAGTGTATTGGGGGA N.A. N.A.
ARX_hs19 chrX:24,880,537-24,881,987 1451 CTTAAGCCTTTCAATGACTT GTAACACTGAACATAGGTAT N.A. N.A.
ARX_hs20 chrX:24,883,965-24,885,114 1150 ATGAGGTGTATTTATTCTCA CAATTAGCTTACGATCTATA N.A. N.A.
ARX_hs21 chrX:24,902,120-24,903,573 1454 GATCAATCAGAGTGAACTTAT GCTGACAGCAAGAACAGGTA N.A. N.A.
ARX_hs22 chrX:24,941,098-24,942,121 1024 GACATTAGGTTAACCTAGA ATATGCCTTCGAATTCCAGT N.A. N.A.
ARX_hs23 chrX:24,961,145-24,962,651 1507 CTCTCCACTCTCCACTGTAAC ATTTCAGGTTGAAAGAAGGA N.A. N.A.
ARX_hs24 chrX:24,972,050-24,973,102 1053 TCTGCTAAGCAGCTGCTAGA CTCACAAATGTCCATGCTCCTA N.A. N.A.
ARX_hs25RI chrX:25,020,182-25,021,940 1759 GGAGTCTGAGGGTTTTAGACT GCTTCCGAAACCTTCAAGAT hs145 eye, forebrain, midbrain  (Rada-Iglesias et al., 2011) Not tested
ARX_hs26RI chrX:25,196,624-25,197,659 1036 GCCTGGGTCCTAGCTAAGAAAT CTGTGAGCAGATATTCCAGTA N.A. N.A.  (Rada-Iglesias et al., 2011) Not tested
not tested
Cerebral cortex (cx),ventral and 
dorsal pallium, ganglionic eminences 
(ge), ventral thalamus (vt), 
hypothalamus (hy). Active also adult.
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Supplementary table 1
Suppl. Table 1 (separate Excel document) List of all tested sequences and 
enhancer testing analysis. The coordinates of tested sequences relate to the human 
genome (hg19). Some elements were tested in different sizes. According to their 
function in the reporter gene assays, they were evaluated for reproducible, partially 
reproducible and inconsistent activity. References are given for similar human 
elements and for orthologous mouse sequences that have been tested in the mouse 
previously. 
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Suppl. Fig. 1  arxa in situ hybridization pattern in zebrafish. 
a. Arx expression pattern characterization in 3 dpf embryos by in situ hybridization.
Expression domains are labeled with color-coded arrows explained in C. b. Series of 
transverse sections through wildtype embryonic brain. Note that predominantly 
GABAergic forebrain regions such as the subpallium (Sd, Sv), the preoptic region 
(Po), the ventral thalamus (VT), the hypothalamus (Hy), and the ventral posterior 
tuberculum (PTv) show strongest arx expression. Predominantly glutatamatergic 
regions such as the pallium (P) and the thalamic eminence (EmT) showed weaker arx 
expression, whereas both the habenula (Ha) and the dorsal thalamus (DT) remained 
completely unstained. Asterisks are at the position of the olfactory epithelium.  
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Suppl. Fig. 2  ARX_enhancer:GFP and arxa mRNA colabeling. 
a. arx in situ hybridization pattern as revealed by BCIP/NBT staining. b. arxa mRNA
distribution compared to GFP localization in ARX-enhancer transgenic embryos at 3 
dpf by double staining analysis. Note that the fluorescent in situ hybridization signals 
are weaker than compared to BCIP/NBT stains and therefore the expression domains 
appear smaller. Representative optical sections of confocal scans performed 
horizontally through the embryos are shown for each enhancer. Arrows point to 
regions in which arx mRNA and GFP overlap, in a color-code that corresponds to the 
initial expression pattern description in Figure 1 (purple: pallium, green: ventral 
thalamus). hs2: GFP/arxa mRNA overlap in the floorplate, in the dorsolateral region 
of the ventral thalamus and in the medial and dorsal telencephalon, although in some 
telencephalic areas seem to exclude the proliferative zone. hs8b: GFP/arxa mRNA 
overlap in the ventral thalamus. hs13: the GFP/arxa mRNA overlap in the dorsal 
telencephalon. This becomes more obvious at later stages when hs13 regulated GFP 
becomes more confined to the dorsomedial telencephalon. hs8a: GFP overlapped 
arxa mRNA only in the dorsal telencephalon where arxa is weakly expressed, most of 
the GFP signal further ventral appears ectopic. 
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Suppl. Fig. 3  Projections of ARX neurons.  
Representative images of hs8b and hs8a enhancer transgenic lines that were confocal 
imaged at 6 dpf. The focus is on neuronal projections to identify neuronal populations 
in which human ARX and zebrafish arx genes are active. The arrows point to 
projections originating from the ventral thalamus, which is hs8b regulated domain, 
and follow a color code: (orange) neuronal fibers originating dorsolateral and 
projecting posterior; (blue) fibers originating medial and projecting dorsal into the 
tectum; (grey) fibers originating medial and projecting dorsolateral; (pink) projections 
appearing at 6 dpf that grow anteriorly into the telencephalon. The white arrow labels 
the habenular commissure.  
a to c: Scans of dorsally oriented hs8b:GFP embryos at 3 dpf. a. Optical sections of 
GFP (green) versus acetylated tubulin (red) antibody stained embryos at the level of 
the optic tectum. b.  Optical sections of a live imaged embryo on two different levels 
through the ventral thalamus – the left image has focus on the dorsal region, whereas 
focus in the right image is on the medial region. c. 3D projection from a different live 
imaged embryo and shows a magnification of a 45° rotation in the 2nd image. This 
perspective makes obvious that the fiber bundles projecting posteriorly are originating 
dorsolateral, whereas the projections leading into the tectum and dorsolateral originate 
further ventral and medial. d. Lateral scan of a 3 dpf anti-GFP stained embryo with 
view on the ventral thalamus (eyes removed). The projections had been computer 
tracked and are shown in different rotations (angle of views are indicated in the 
image). e. hs8b:Gal4-UAS:Kaede embryos were imaged at 6 dpf. Optical sections of a 
horizontally performed scan shown from dorsal to ventral. The habenular commissure 
connecting the habenular nuclei on both sides of the diencephalon is strongly labeled 
at 6 dpf. The optic tectum is innervated by fibers originating in the ventral thalamus. 
Labeled ventral thalamic fibers have increased at this stage. Visible now are fine 
fibers that grow anteriorly into the telencephalon (pink arrows).  
f to h: Confocal scans of GFP-expressing 6-dpf-larvae of hs8a enhancer regulated 
Gal4-UAS:GFP transgenic line in three orientations. f. Optical sections through the 
dorsal telencephalon from anterior to further posterior with focus on the pallium and 
the anterior commissure. g. Optical sections with focus on the posterior tuberculum in 
the left image and on the hypothalamus in the right image, which is further ventral. h. 
3-dimensional reconstruction of a horizontally performed scan with 85° lateral 
rotation.  
Abbreviations: (ac) anterior commissure, (dienc) diencephalon, (h) hypothalamus, 
(Hc) caudate hypothalamus, (Hi) intermediate hypothalamus, (OT) optic tectum, (p) 
pallium, (PTv) ventral posterior tuberculum, (s) subpallium, (tel) telencephalon 
(dorsal), (vt) ventral thalamus. (After Mueller and Wullimann 2005).  
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Suppl. Fig. 4  Differential activity of hs8a and hs13 in the developing forebrain.  
hs13-regulated GFP is restricted to the medial telencephalon and is distributed widely 
in the preoptic region and hypothalamus, while hs8a has a broad activity in the 
dorsomedial telencephalon and in the thalamus at 1 dpf. With very similar activity of 
the enhancers at 3 dpf, the expression varies again at 5 dpf. Hs8a driven GFP is in the 
medial and lateral telencephalon, while GFP in hs13 transgenic larvae is restricted to 
the medial part including the proliferative zone. Abbreviations: (H) hypothalamus, 
(Po) preoptic region, (Tel) telencephalon, (VT) ventral thalamus. 
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Suppl. Fig. 5  Upregulation of hs8a regulated GFP was quantified by confocal 
microscopy. 
hs2 and hs8a regulated GFP was significantly upregulated in embryos injected with 
arxa morpholino. No significant differences could be established in hs9:GFP embryos. 
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Supplemental Fig. 6  hs8a regulated overexpression of arx caused malformation 
of the eyes.  
The eyes grew towards the midline in most of the analyzed specimen. Shown here is 
an example with a severe eye extrusion (marked by the pink arrows). hs8a has a 
strong and broad regulatory activity at 1 dpf in the telencephalon and medial 
diencephalon  (shown in lateral view) that may cause these disturbances. 
 
  
58
59
Suppl. Fig. 7. Computational prediction of transcription factor binding sites 
(TFBS) overlying the five human ARX enhancers. TFBS were detected according 
to the binding sites predicted by Jaspar (Green) and ConSite (Blue) and matches 
between Jasper and ConSite (Red). TFBS from human and mouse matrices are 
indicated in capital and lower letters, respectively. 
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